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Abstract
The leishmanioses, vector-borne diseases caused by the trypanosomatid protozoan Leishmania, are transmitted to
susceptible mammals by infected phlebotomine sand flies that inoculate promastigotes into hemorrhagic pools created in
host skin. We assumed that promastigotes are delivered to a blood pool, and analyzed early promastigote interactions (0–
5 min) with host components, which lead to parasite endocytosis by blood leukocytes, and to host infection. Promastigotes
were incubated with NHS or with heparinized blood in near-physiological conditions, and we used cell radioimmunoassay
and flow cytometry to measure the on-rate constants (k+1) of promastigote interactions with natural opsonins and
erythrocytes. We obtained quantitative data for parasitized cells to determine the time-course of promastigote binding and
internalization by blood leukocytes. In these reactions, promastigotes bind natural opsonins, immune adhere to
erythrocytes and activate complement cytolysis, which kills ,95% of promastigotes by 2 min post-infection. C3-
promastigote binding is a key step in opsonization; nascent C3-promastigotes are the substrate for two simultaneous
reactions, C3-promastigote immune adherence (IA) to erythrocytes and complement-mediated promastigote killing. The k+1
for IA was 75-fold greater than that for promastigote killing, showing that IA facilitates promastigote endocytosis and
circumvents lysis. At 5 min post-infection, when reaction velocity is still linear and promastigote concentration is not
limiting, 17.4% of granulocytes and 10.7% of monocytes had bound promastigotes, of which ,50% and ,25%, respectively,
carried surface-bound (live) or internalized (live and dead) leishmanias. Of other leukocyte types, 8.5% of B cells bound but
did not internalize promastigotes, and T cells, NK cells and CD209
+ dendritic cells did not bind parasites. These data show
that, once in contact with blood, promastigote invasion of human leukocytes is an extremely rapid and efficient reaction,
and suggest that the IA reaction constitutes a central strategy for this parasite in subverting host innate immune defenses.
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Introduction
The leishmanioses are a group of vector-borne zoonotic diseases
caused by trypanosomatid parasites of the genus Leishmania.
Leishmanias are heteroxenous protozoa with a life cycle in two
different hosts, in the Psychodidae diptera of the genera Phlebotomus
and Lutzomyia and in mammals. In the sand fly, Leishmania lives in
the digestive tract as an extracellular motile flagellated promas-
tigote; in mammals, it dwells as a sessile aflagellated amastigote
inside macrophages [1].
Female phlebotomine sand flies are hematophagous arthropods
that require blood proteins for oogenesis. Sand flies feed from
hemorrhagic spots created in the host dermis. When feeding on a
Leishmania-infected host, flies can ingest amastigotes or amastigote-
laden macrophages and become infected. In the vector gut,
amastigotes differentiate first into procyclic promastigotes and
subsequently into more mature promastigote morphotypes.
Promastigote differentiation generates mature, non-dividing par-
asites termed metacyclic promastigotes, considered the Leishmania
forms that infect mammals [2]. In heavily infected flies, the lumen
of the food canal appears choked by a promastigote-derived
mucin-like gel (PSG) containing large numbers of promastigotes
embedded in a filamentous proteophosphoglycan (fPPG) matrix
[3]. During sand fly engorgement, PSG limits the food flow and
jams the vector feeding system, hampering intake of an adequate
blood meal; this prompts sand fly regurgitation and delivery of
promastigotes together with saliva and fPPG to the intradermal
pool, thus causing infection [4].
Leishmaniosis is transmitted to mammalian hosts when infected
sand flies take a second blood meal [5,6]. Cases of Leishmania
infection have been reported in humans with no apparent blood
uptake by the vector; in this case, promastigotes are presumably
deposited into the extracellular matrix in the dermis [7–9]. Parasite
transmission without blood involvement is also described in
experimental rodent infection, in which a considerable fraction of
transmitting flies apparently did not ingest blood while feeding
[10,11]; nevertheless, one of these studies shows that promastigote
transmission was 2.6-fold higher among flies that had taken a
second blood meal [10]. Studies of natural sand fly feeding habits
showed that a majority (63–68%) of females trapped around animal
shelters were blood-fed, and that 58.7% of blood-fed flies were
PCR-positive for Leishmania DNA, double the number of positives
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uptake by the vector is frequent in leishmaniosis transmission.
In natural Leishmania infection, promastigotes can therefore be
delivered into hematomas or into a bloodless context in the skin.
This is not an irrelevant issue, as promastigotes interact in blood
with leukocyte populations, whereas in the dermal matrix they
interact with fibroblasts, dermal dendritic cells (DDC), mast cells,
and macrophages [13,14]. The environment and cell target
repertoire in which infection occurs can influence the course of
disease development, as well as the type and intensity of immune
response induced [15,16].
Recent work in mice explored parasite fate after intradermal
promastigote inoculation [13,17], but the physiological and
functional differences between the innate immune systems of mouse
and man preclude direct extrapolation of results. In humans,
comprehensive studies of the initial stages of leishmaniosis
transmission in the blood pool are lacking, and most infection
studies have been carried out using isolated leukocyte populations
[18–26]. For a previous study, we designed an ex vivo model of
infection inhuman bloodtoanalyze the earlystagesof promastigote-
host interaction [27]. Opsonisation, binding and internalization of
promastigotes by target leukocytes occur within minutes (early
infection); ensuing reactions triggered by the cells that endocytose
parasites take hours or days to develop or to reach full intensity.
Using two Leishmania species with different tropism, L. amazonensis
and L. donovani, we studied the kinetics of early Leishmania infection of
human blood, and measured the rate constants (k+1) of promastigote
opsonization reactions and the kinetics of promastigote binding and
internalization by blood leukocytes during the very early infection
period (0–5 min).Based onthese data,we proposea kineticmodel of
ex vivo human blood infection by Leishmania promastigotes.
Materials and Methods
Ethics statement
This study was approved by the Ethics Committee (Comite ´d e
E ´tica de la Investigacio ´n y Bienestar Animal) of the Instituto de
Salud Carlos III (Ref CEI PI 12_2009). All human participants
were volunteers and gave written consent.
Parasites and cultures
Leishmania donovani Khartoum 1246 (MHOM/SD/43/124) and
Leishmania amazonensis Maria (MHOM/Br/79/Maria) isolates were
cultured in RPMI 1640 complete medium as described [27].
Stationary phase parasites were harvested by centrifugation
(1,5006g, 15 min, 20uC), washed twice in PBS pH 7.2, and
adjusted to the desired concentration.
Promastigote labeling
Promastigotes were labeled with [
111In]-oxine as described [27].
For labeling with 5-chloromethylfluorescein diacetate (CMFDA;
Invitrogen, Carlsbad, CA), early stationary phase promastigotes in
1 ml culture medium (,2610
7 cells) were incubated (15 min,
37uC) with 3 mM CMFDA; after incubation, cells were washed in
PBS by centrifugation (11,0006g, 1 min) and adjusted to 10
7
CMFDA-labeled promastigotes/ml.
Human blood and serum collection
Blood was drawn from healthy donors into preservative-free
heparin (10 IU/ml), kept at room temperature (20uC), and used in
the IA reaction within hours of extraction. Normal human serum
(NHS) was collected from clotted blood (20uC, 30 min) and serum
aliquots stored in liquid nitrogen.
Antibodies
Monoclonal antibodies (mAb) used were anti-CD15-PE (clone
HI98), -CD14-allophycocyanin (APC) (clone M5E2), -CD3-PE-
Cy5 (clone 5HIT3a) and -CD56-APC (clone B159) (all from BD
Pharmingen, San Jose, CA), -CD19-APC (clone HIB19; BioLe-
gend, San Diego, CA) and CD209-PE (clone eB-h209;
eBioscience, San Diego, CA). FITC-labeled rabbit anti-human m
chain was from Dako (Glostrup, Denmark). mAb SIM 27–49
(anti-human C3 a chain; IgG2b) was Cy5-labeled (GE Healthcare)
following manufacturer’s instructions. Goat anti-m (50 mg) and
SIM27–49 (25 mg) were labeled with 5 ml sodium
125I (carrier-free,
105.36 mCi/ml; DuPont/NEN Life Science) in Iodogen (Pierce,
Rockford, IL)-coated tubes and [
125I]-SIM27–49 activity was
measured [28].
Measurement of reaction on-rate (k+1) constants
The Leishmania opsonization pathway can be depicted as a
sequence of four reactions: 1) promastigote+natural antibo-
diesRpromastigote-IgM, 2)+complementRpromastigote-C3 (na-
scent promastigote-C3 are the substrate of two subsequent
competing reactions), 3) promastigote-C3+ERpromastigote-E IA
and 4) promastigote-C3+C5b-C9Rpromastigote propidium io-
dide (PI) uptake. In 25% NHS, the concentrations of anti-
Leishmania IgM antibodies ([IgM5]), complement components and
receptors for complement C3b fragments on erythrocytes ([E-
CR1]) are in moderate to great excess over the concentration of
promastigote IgM binding sites ([Pmbs]) and bound C3b with
which these molecules interact in reactions (1) to (4). To simplify
measurement of on-rate constants, reactions (1) to (4) were
considered one-way bimolecular interactions of the type A
reactant+B reactantRP (product), and analyzed as described
[29,30]. The rate of P formation is described as
v~dP ½  =dt~kz1 A ½  B ½  ,
in which k+1 is the second-order on-rate constant for the reaction.
When the concentration of reactant [B] is .. [A], [B] does not
change substantially and the reaction is said to be pseudo-first-
order. The velocity equation is written
dP ½  =dt~k
app A ½ 
Author Summary
Leishmania infection is transmitted to mammalian hosts by
phlebotomine sand flies. During the vector’s bloodmeal,
promastigotes are inoculated into hemorrhagic spots in
the skin or are delivered into the extracellular matrix of the
dermis. In the first case, blood is involved in transmission;
in the second, it apparently is not. This is important, as the
cellular milieu of infection can be critical for induction of
the anti-parasite immune response and the subsequent
course of disease. In humans, there are few comprehensive
studies of the initial stages of Leishmania transmission in
blood. Using blood to mimic the skin hematoma, we
carried out kinetic and quantitative analyses of the
reaction with serum and blood components of promasti-
gotes from two Leishmania species with different tropism.
We describe the kinetics of the promastigote reaction
pathway that leads to blood infection and provide
quantitative data for the cell types infected in the first
five minutes of leishmaniosis transmission.
Time Course of Human Leishmania Infection
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app, the apparent pseudo-first-order rate constant, is
k
app=k +1 [B]. The rate expression simplifies to L (Bmax/
Bmax2Bt)=k
app t, in which L is the natural logarithm, Bmax is
the percent of maximum binding, and Bti, the percent of binding
at times ti. Kinetic data plotted as L (Bmax/Bmax2Bti) against
incubation time (ti) render a straight line of slope k
app. The second-
order rate constant of the reaction is obtained from k+1=k
app/[B].
Sigmoid kinetic data were fitted by non-linear regression using a
four-parameter Hill equation (SigmaPlot 9.0).
Promastigote-IgM binding
Aliquots (50 ml) of L. donovani or L. amazonensis promastigotes
(10
7/ml) were mixed with 50 ml 50% PBS-diluted pooled NHS
and incubated for varying time periods between 0 and 60 sec. The
reaction was terminated by dilution with 1 ml cold (4uC) PBS
containing 2.5% FCS and 0.05% NaN3 (PFS buffer), followed by
centrifugation (11,0006g, 1 min). To avoid cell loss, untreated
promastigotes (5610
6) were then added to the pellet and the
samples washed twice in cold PFS (11,0006g, 1 min) to remove
traces of serum IgM that could block
125I-goat anti-m binding.
Parasites were resuspended in 0.2 ml PFS containing 2610
5 cpm
125I-goat anti-m (10
7 cpm/mg), incubated 1 h on ice, washed twice
as above, and promastigote-bound antibody was determined.
Promastigote-C3 deposition reaction
Assay conditions were identical to those for promastigote-IgM
binding, except that the reaction was terminated by dilution with
1 ml cold PFS containing 5610
6 untreated promastigotes, and
tube contents were washed twice by centrifugation (11,0006g,
1 min). Promastigote pellets were resuspended in 0.2 ml PFS
containing 5610
5 cpm [
125I]-SIM27–49 (6610
6 cpm/mg) and
incubated 1 h on ice. After incubation, samples were processed
as above and promastigote-bound [
125I]-SIM27–49 cpm deter-
mined.
Promastigote-erythrocyte immune adherence reaction
Aliquots (50 ml) of [
111In]-labeled promastigotes (10
7 cells/ml)
were mixed with 50 ml heparinized blood and incubated for
varying time periods (0 to 60 sec). EDTA (final concentration
5 mM) was added to terminate the reaction, and samples were
immediately fractionated by centrifugation (5006g, 3 min)
through 1.5 ml 72% Percoll. [
111In]-labeled E-bound (E pellet)
and free parasites (Percoll solution) were then filtered through glass
fiber discs (GF/C; Whatman), washed three times with cold PBS,
and retained [
111In] cpm determined.
Complement-mediated promastigote propidium iodide
uptake
Single aliquots (50 ml) of L. donovani or L. amazonensis promas-
tigotes (10
7/ml) were mixed with 50 ml 50% PBS-diluted pooled
NHS and incubated for varying times (0 to 140 sec). The reaction
was terminated by diluting the sample with 1 ml FACSFlow
sheath fluid (BD Biosciences, San Jose ´, CA) containing 5 mg/ml
propidium iodide (PI; Sigma-Aldrich, St. Louis, MO) and PI
uptake by killed promastigotes was measured in a FACSCalibur
flow cytometer (BD Biosciences) [28].
Determination of complement-resistant parasite
numbers in stationary promastigote inoculum
To estimate the number of live parasites after opsonization in
different NHS concentrations, single aliquots (0.3 ml) containing
L. amazonensis promastigotes (2610
5), 10 mg/ml PI, and serially
diluted (50% to 0.78%) NHS were incubated (37uC) for 1 to
9 min. Leishmania killing was determined by measuring promasti-
gote PI uptake in real-time by flow cytometry (FACSCalibur). The
precise percentage of complement-killed promastigotes cannot be
determined by flow cytometry due to background signal from
small particles and debris in stationary cultures; to reduce
background, promastigotes were gated (SSC vs. FSC) and PI
uptake emission measured in a dot plot of FL-2 (585/42 nm) vs.
time (sec); data were analyzed with CELLQuest software (Becton
Dickinson).
To measure promastigote complement-resistance in 50% NHS,
aliquots (50 ml) of promastigotes (2610
6/ml) of six L. amazonensis
stationary cultures (96.6% viable) were incubated in 50% pooled
NHS (37uC, 5 min), after which promastigote PI uptake was
measured by flow cytometry. Additional experiments (n=3)
compared PI uptake by stationary promastigotes and promasti-
gotes enriched in metacyclic forms by centrifugation in a 10% to
30% Ficoll density gradient (‘‘top 10’’ promastigotes) [31,32].
Briefly, 1 ml of stationary-phase promastigotes (2610
8/ml) was
layered onto a discontinuous gradient of 2 ml 10% and 2 ml 30%
Ficoll solutions, and centrifuged (13006g or 3656g, no brake;
22uC, 10 min). Promastigotes at the 10% Ficoll interface and the
upper part of the 10% Ficoll cushion were pooled, diluted with
RPMI 1640 complete medium and washed by centrifugation
(15006g, 15 min). The pellet, resuspended in complete RPMI
1640, was washed again and adjusted to 2610
7cells/ml. Aliquots
(50 ml) of stationary-phase and ‘‘top 10’’ promastigotes were
incubated (37uC, 5 min) in 50% NHS; for controls, NHS was
replaced by PBS. The reaction was terminated by dilution with
complete RPMI 1640 and centrifugation. Promastigote PI
incorporation was determined by flow cytometry after incubating
a1 0ml aliquot of each sample in 0.2 ml of PBS containing 2 mlP I
(1 mg/ml). Promastigotes were gated (SSC vs. FSC) to eliminate
small particles and debris, and PI uptake emission was collected in
the FL2 detector through a 585/42 nm band pass filter.
After opsonization in different NHS concentrations, the
percentage of live promastigotes was quantitated by light
microscopy. Aliquots (50 ml) of stationary-phase L. amazonensis
promastigotes were incubated (37uC, 5 min) in serially diluted
NHS (1:2; 50% to 0.78% concentration). The reaction was
terminated by dilution with PBS, and live parasites counted under
a microscope. It should be noted that after parasite incubation in
$3% serum, motile promastigotes with a slender shape are
observed very infrequently. Most parasites registered as viable
undergo marked changes in cell geometry, lose the flagellum and
become ellipsoidal or small round refractile bodies with limited but
noticeable drifting; such changes complicate identification.
Determination of leukocyte binding of promastigotes
To measure initial blood leukocyte binding of opsonized
leishmanias, we incubated CMFDA-labeled promastigotes with
heparin-treated blood and used flow cytometry to determine the
percentage of each leukocyte subpopulation that bound parasites
after 5 min. We mixed 1 ml CMFDA-labeled L. amazonensis or L.
donovani promastigotes (10
7/ml) with 1 ml heparinized blood,
followed by incubation (37uC, 5 min, waterbath). The mixture was
divided into 200 ml aliquots and E were lysed by incubation with
2 ml E-lysing reagent (EasyLyse, DakoCytomation; 10 min). Cells
were washed in PBS by centrifugation (5006g, 10 min, 20uC).
Each pellet was incubated (30 min, 20uC) with one of the
following mAb: anti-CD14-APC, -CD15-PE, -CD3-PE-Cy5,
-CD56-APC, -CD19-APC or -CD209-PE. Cells were washed in
PBS by centrifugation (5006g, 10 min). Leukocyte subpopulations
were identified by flow cytometry and represented in a dot plot as
side scatter (SSC) vs. the specific fluorescent label of each
Time Course of Human Leishmania Infection
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promastigotes was analyzed in a secondary plot by independently
representing the fluorescence intensity of each gated mAb-labeled
population vs. that of cell-bound CMFDA-labeled promastigotes
(FL1, green 530 nm) following excitation with a 488 nm argon ion
laser. To account for nonspecific binding, we subtracted
promastigote binding at time zero from all values registered. In
heat-inactivated serum (HIS), promastigote binding by leukocytes
was negligible at the times tested (Fig. S1). Use of HIS as control
would require cell separation from plasma and its replacement
with HIS, a less physiological approximation of infection
conditions. The number of events acquired by the cytometer
varied from 5610
4 to 2610
5. A total of 5610
3 events were
counted for each leukocyte population, except in the case of
CD209
+ cells, for which 2610
5 leukocytes were acquired and 150
events counted.
Time-course analysis of promastigote binding and
internalization by granulocytes and monocytes
To measure the kinetics of promastigote binding and internal-
ization by granulocytes and monocytes, 50 ml aliquots of
heparinized human blood were mixed with 50 ml CMFDA-labeled
Leishmania promastigotes (10
7/ml) and incubated (37uC) for various
times (0, 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 10, 30 and 60 min). The
reaction was terminated by addition of 2 ml E-lysing reagent.
After 10 min incubation, 3 ml of sheath fluid were added to each
tube and centrifuged (5006g, 5 min); the pellet was washed with
5 ml sheath fluid as above and resuspended in 200 ml sheath fluid.
Samples were divided in two 100 ml aliquots. To quench
extracellular fluorescence, 10 ml trypan blue (TB) solution
(10 mg/ml; final concentration 1 mg/ml) were added to one
sample. To register the percentage of leukocytes that bound and
internalized promastigotes, granulocytes and monocytes were
gated by SSC vs. forward scatter (FSC) and plotted independently
in a secondary plot of SSC vs. FL1 (green, 530 nm) following
excitation with a 488 nm argon ion laser. Quenched samples were
acquired for 10 min after TB addition. A total of 2610
4 events
were acquired for each measurement and analyzed with
CELLQuest software (BD Biosciences).
Results
For kinetic analysis of the early mechanisms of ex vivo human
blood infection by Leishmania, we studied promastigote interactions
with NHS and with heparin-treated blood. Experiments were
performed in conditions of near-physiological time (0–360 sec),
temperature (37uC) and serum or blood concentrations (25% and
50%, respectively), with a constant reaction volume (0.1 ml) and
promastigote inoculum (5610
5) throughout the study. This
inoculum size corresponds to ,5000 promastigotes delivered in
a blood meal of 0.5 ml, well within the range of experimentally
determined values [6,11,33]. All kinetic data were obtained from
initial rate measurements, when reaction velocity is linear with
time.
To infect blood, we used early stationary culture promastigotes
taken not later than two days after they had reached maximum
growth. Promastigote populations from early stationary cultures
are heterogeneous; nevertheless, after contact with human blood,
whose complement is cytolytic for Leishmania, only serum-resistant
metacyclic promastigotes are alive [34]. We assume that
promastigotes that survive .3 min in blood constitute the parasite
population with infective capacity. Alternatively, one might use
parasite inocula enriched in metacyclic promastigotes by negative
selection methods, but these procedures also render heterogeneous
populations [31,35–38], and inoculum enrichment with metacyclic
promastigotes would boost infection artificially.
To ascertain the number of complement-resistant promastigotes
in the inocula, we measured PI uptake in real time by L.
amazonensis parasites incubated with serially diluted pooled NHS.
The extent of promastigote killing by human complement is
dependent on serum dilution (Fig. S2). At $25% NHS, ,90% of
promastigotes incorporated PI very rapidly; at higher serum
dilutions, promastigote PI uptake showed a gradual delay,
although the percentage of promastigotes killed by the end of
incubation reached maximum levels and was similar to that
observed at 50% NHS. In 3% NHS and in more dilute serum
conditions, most promastigotes were alive.
We used flow cytometry to assess the percentage of
complement-resistant parasites after incubation in 50% pooled
NHS (37uC, 5 min). Complement-mediated PI uptake by
promastigotes was studied in parasites of six L. amazonensis
stationary cultures. In three cultures, we compared PI uptake by
stationary promastigotes and stationary promastigotes enriched in
‘‘top 10’’ metacyclic forms on a Ficoll density gradient.
Promastigote aliquots were incubated in 50% NHS and PI
incorporation determined by flow cytometry. Promastigotes from
stationary cultures showed 4.4%61.0% (range 2.8% to 6.8%) live
parasites and controls, 96.5%61.3%. Complement resistance was
similar in stationary promastigotes and ‘‘top 10’’ stationary
promastigotes in 50% NHS; the former showed 4.8%61.1% and
the latter, 4.6%61.1. ‘‘Top 10’’ stationary promastigotes were
thus not more resistant to human complement. Average recovery
of ‘‘top 10’’ promastigotes was 16% and 35% after centrifugation
at 13006g and 3656g, respectively; this indicates that the small
percentage of complement-resistant promastigotes in stationary
cultures is not a function of low levels of ‘‘top 10’’ metacyclic
forms, but that promastigotes resistant to lysis in 50% NHS are
very infrequent.
To calculate the number of live promastigotes by a non-flow
cytometric method, we used light microscopy. The percentage of
live parasites in serum concentrations from 50% to 0.78% is
indicated (Fig. S3). This method shows an average percentage of
live promastigotes of 5.0%60.7% (range 3.2% to 6.9%).
Infection of blood with promastigotes calls for the use an anti-
hemostatic agent such as heparin. To determine the inhibitory
capacity of heparin in Leishmania opsonization, we studied real-
time PI uptake (i.e., killing) by L. amazonensis promastigotes
opsonised with NHS, normal plasma, normal plasma treated with
50 mg/ml lepidurin (Refludin; Pharmion) or with heparin at
concentrations of 10, 12.5, 15, 20, 40 or 80 IU/ml (Fig. S4). The
velocity of promastigote PI uptake in plasma treated with 10 to
40 IU/ml heparin lagged by ,10 sec relative to the velocity of
promastigote PI uptake in NHS. To observe a ,40-sec delay
compared to NHS or to lepirudin-treated plasma, 80 IU/ml
heparin was needed. Reaction intensity was identical in NHS, in
lepirudin-treated plasma, and in plasma treated with different
heparin concentrations; after 2 min incubation, all promastigotes
had incorporated PI to the same extent. These data indicate that
heparin does not interfere appreciably with parasite opsonisation
in heparin-treated (10 IU/ml) human blood.
We also analyzed the influence of heparin on promastigote
binding to granulocytes and monocytes in heparin-treated (10 IU/
ml) human blood. Binding of L. amazonensis promastigotes by
granulocytes and monocytes after 1, 3, and 5 min incubation in
heparin-treated blood was indistinguishable from that in lepidurin-
treated (50 mg/ml) blood (Fig. S5). At a 10 IU/ml concentration,
heparin does not affect the course of human blood infection by
Leishmania.
Time Course of Human Leishmania Infection
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promastigotes
Non-immune serum from most vertebrates contains natural anti-
trypanosomatid antibodies that act as an innate recognition system
in the host [28,39]. To determine the velocity of IgM binding to
Leishmania parasites, we measured the association rate constant (k+1)
byincubating promastigotesinNHSforvaryingtimes.Thereaction
was terminated by sample dilution with PFS, and promastigote-
bound IgM was measured using
125I-goat anti-m. Pentameric IgM
(IgM5) binding reached maximum after 20 sec incubation for both
L. donovani (Fig. 1A) and L. amazonensis (Fig. 1B). [IgM5] in adult
NHS is ,1.3 g/L; if the Mr of IgM5 is considered to be 950,000,
thenserum[IgM5]is,1.4610
26 M.Exhaustive adsorptionof25%
NHS with L. amazonensis and L. donovani promastigotes removed
,15%and ,30%ofIgM5, respectively[28], indicating that [IgM5]
anti-L. amazonensis in unadsorbed serum is ,0.5610
27 M and that
of anti-L. donovani, ,1610
27 M. At equilibrium, L. amazonensis and
L. donovani promastigotes bind ,5,000 and ,2,500 IgM molecules/
cell, respectively. Early in the promastigote-IgM5 interaction,
antibody binding is assumed to be monovalent [29], which would
render [Pmbs]o nL. amazonensis promastigotes of ,4.1610
211 M
and on L. donovani promastigotes of ,2.1610
211 M. In a
monovalent promastigote-IgM5 interaction, the [IgM5]/[Pmbs]
ratio is ,1,300:1 in L. amazonensis and ,5,000:1 in L. donovani;i n
the case of a decavalent promastigote-IgM5 interaction, this ratio
would be ,130:1 (L. amazonensis)a n d,500:1 (L. donovani). In both
cases, the promastigote-IgM5 interaction obeys pseudo-first-order
kinetics. The percentage of IgM5 bound, plotted as L (IgM5max/
IgM5max2IgM5ti)against reactiontime (ti),givesstraightlineswhose
slopes are the k
app values of the reactions, ,0.23 sec
21 for L.
amazonensis and ,0.18 sec
21 for L. donovani. Second-order rate
constants were obtained from k+1=k
app/[IgM5], with values of
,4.4610
6 M
21 sec
2160.05610
6 M
21 sec
21 for L. amazonensis
and ,1.8610
6 M
21 sec
2160.05610
6 M
21 sec
21 for L. donovani.
The mean k+1 for natural IgM5 binding to promastigotes of both
Leishmania species was ,3610
6 M
21 sec
21.
Time course of C3 deposition on Leishmania
promastigotes
Early in Leishmania infection, human complement has effects
both advantageous for and harmful to the promastigote.
Complement activation triggers binding of C3 fragments to the
parasite, which mediates IA and Leishmania internalization by host
leukocytes; however, promastigote-C3 binding also nucleates
assembly of the C5 convertases, activating the complement lytic
cascade that kills the parasites.
To establish how Leishmania circumvents complement effector
activity, the kinetics and velocity of complement activation must
be understood. We incubated promastigotes with NHS and
measured the reaction time course and k+1 of promastigote-C3
binding. Promastigote-C3 binding follows a sigmoidal course, with
an initial ,30-sec lag during which 10 to 20% of total C3 ligands
are fixed; C3 molecules that bind during this lag period probably
attach to IgM. This amount of C3 is insufficient to activate the
alternative pathway and the lytic cascade, but is sufficient to
establish multipoint contacts with clustered E-CR1, triggering the
IA reaction [40–42]. Thereafter, C3 binds at an exponential rate
for ,1 min, during which C3 is bound at an average rate of
Figure 1. Time course of normal serum IgM binding to L. donovani and L. amazonensis promastigotes. Aliquots (50 ml) of L. donovani or L.
amazonensis promastigotes (10
7/ml) were mixed with 50 ml 50% NHS and incubated (37uC) for varying times. Promastigotes were then washed by
centrifugation (11,0006g, 1 min) with cold PFS. Untreated promastigotes (5610
6) were added to the pellet, washed twice in cold PFS, and
promastigote-bound IgM measured with
125I-goat anti-m antibody. Each point (mean of triplicate samples) is expressed as a percentage of the point
of maximum IgM binding in one representative experiment of five performed for each species. (A) L. donovani, (B) L. amazonensis. Insets: plots of L
(IgM5max/IgM5max2IgM5ti) against reaction time (ti), from which k
app values were derived.
doi:10.1371/journal.pntd.0000743.g001
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molecules/sec for L. amazonensis (Fig. 2B). During the C3 lag
period, IgM5 binding to Leishmania reaches maximum and
the [IgM5] bound is ,4.1610
211 M( L. amazonensis) and
,2.1610
211 M( L. donovani).
In 25% NHS, the concentration of complement classical pathway
components ([C1–C3]) ranges from 4.5610
28 Mf o rC 1t o
1.75610
26 M for C3. If the C1 interaction with promastigote-
bound IgM5 is considered the rate-limiting step in classical
complement pathway activation, the serum C1 concentration is
,2000-fold greater than that of promastigote-bound IgM5 for
L. amazonensis and ,1000-fold for L. donovani. [C1–C3] is ..
[promastigote-IgM5], and C3 binding to promastigotes would
proceed under pseudo-first order conditions. We analyzed the late
phase of the exponential course, fitting the data to a pseudo-first order
rate equation. Plots of the percentage of C3 bound as the L (C3max/
C3max2C3ti)a g a i n s tt i m e( t i)y i e l d e dk
app of ,0.063 sec
21 for L.
amazonesis and ,0.061 sec
21 for L. donovani. The second-order rate
constants were ,3.6610
4 M
21 sec
2160.01610
4 M
21 sec
21 for L.
amazonesis and ,3.5610
4 M
21 sec
2160.005610
4 M
21 sec
21 for L.
donovani; the mean k+1 value for Leishmania promastigote-C3
opsonization was ,3.5610
4 M
21 sec
21.
Promastigote-erythrocyte immune adherence reaction
In human blood, C3-opsonized promastigotes immune
adhere to erythrocytes [27]. IA is a C3-mediated innate
immune mechanism, almost ubiquitous in mammals, that
enhances phagocytosis and clearance of opsonized microor-
ganisms from blood [43]. To study the velocity of IA in the
reaction sequence of Leishmania infection, we followed the
kinetics of IA complex formation and determined the on-rate
constant of the interaction between promastigote-C3 and
erythrocytes.
Within seconds of serum contact, nascent C3-opsonized
promastigotes bind to CR1 on E and form promastigote-E IA
complexes. This interaction has an initial lag time of ,15 sec
followed by a period in which IA complexes are formed at an
exponential rate until the reaction reaches completion at 30 to
40 sec of incubation. The IA reaction is so rapid that it gives the
impression that promastigote-E binding proceeds before C3
opsonization (Fig. 3A, B). Considering the average number of
CR1 molecules per erythrocyte to be 500 [44], the [E-CR1] in this
assay is ,2.1610
29 M. At equilibrium, L. donovani promastigotes
bind ,180,000 C3 molecules/cell [28]; at the onset of the IA
reaction in L. donovani (,12 sec), there are ,27,000 C3 molecules
(,15% of maximum binding) bound to promastigotes, indicating
a promastigote-bound C3 concentration ([Pm-C3]) of ,2.26
10
210 M. At the onset of the IA reaction, the [E-CR1]:[Pm-C3]
ratio is thus ,10. In the case of L. amazonensis, at equilibrium
promastigotesbind,120,000C3molecules/cell,and attheonsetof
the IA reaction (,15 sec) there are ,22,000 C3 molecules bound/
cell (,18% of maximum binding); this yields a [Pm-C3] of
,1.8610
210 M, and a [E-CR1]:[Pm-C3] ratio of ,12. In these
assays, the [E-CR1] exceeds the [Pm-C3] by ,10-fold and the
reaction proceeds under pseudo-first-order conditions. Regression
analysis of the percentage of IA plotted as L (IAmax/IAmax2IAti)
against incubation time (ti) yielded k
app values of ,0.15 sec
21
(L. amazonensis) and ,0.21 sec
21 (L. donovani), and k+1 constants of
,0.8610
8 M
21 sec
2160.02610
8 M
21 sec
21 (L. amazonensis)
and ,1610
8 M
21 sec
2160.04610
8 M
21 sec
21 (L. donovani). The
average k+1 for the Leishmania IA reaction was thus
,9610
7 M
21 sec
2160.4610
7 M
21 s
21.
Figure 2. Kinetics of C3 deposition on L. donovani and L. amazonensis promastigotes. Duplicate aliquots (50 ml) of promastigotes (10
7/ml)
were mixed with 50 ml 50% NHS and incubated (37uC) for the times indicated. Promastigotes were then washed twice by centrifugation (11,0006g,
1 min) in cold PFS, and promastigote-bound C3 measured with
125I-SIM27–49 (anti-human C3a mAb). C3 binding (mean of duplicate values) from
one representative experiment. (A) L. donovani (n=4), (B) L. amazonensis (n=5). Insets: plots of L (C3max/C3max2C3ti) against time (ti), from which k
app
constants of C3 deposition reactions were obtained.
doi:10.1371/journal.pntd.0000743.g002
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Complement activation leads to assembly of the C5 convertases
(C4b3b2a, C3b2Bb), triggering the cytolytic complex (C5b–C9)
that causes promastigote death. We measured the time course of
parasite membrane damage by complement as PI uptake and
determined the on-rate constant of the reaction. The kinetics of
promastigote PI uptake is very rapid; it begins at ,50 sec after
complement activation and by ,100 sec after serum contact, most
leishmanias have incorporated PI (Fig. 4A, B). During that period,
the [Pm-C3] varies from ,6610
210 to ,1610
29 Mi nL.
amazonensis and from ,5610
210 to ,1.5610
29 Mi nL. donovani.
In 25% human serum, the concentration of C5b–C9 compo-
nents ranges from 9.2610
28 M for C5 to 2.1610
27 M for C9.
C5b deposition is considered the rate-limiting step; at the onset of
the lytic reaction, [C5b–C9] is greater than [promastigote-C3] by
,150-fold (L. amazonensis) and ,180-fold (L. donovani). The rate of
complement-mediated PI uptake by promastigotes was calculated
by plotting the percentage of PI incorporation as L (PImax/
PImax2PIti) against incubation time (ti). k
app values for L.
amazonensis and L. donovani PI uptake were 0.13 sec
21 and
0.083 sec
21, respectively, and the k+1 constants were ,1.46
10
6 M
21 sec
2160.008610
6 M
21 sec
21 (L. amazonensis) and
,0.9610
6 M
21 sec
2160.005610
6 M
21 sec
21 (L. donovani). The
average k+1 value for promastigote PI uptake was ,1.26
10
6 M
21 sec
21.
The on-rate constant values of opsonization, immune adher-
ence, and PI uptake reactions of L. donovani and L. amazonensis
promastigotes in human blood are summarized in Table 1.
Leukocyte subpopulations that bind promastigotes in
early infection in blood
To measure initial blood leukocyte binding of opsonized
leishmanias, we incubated CMFDA-labeled promastigotes with
heparin-treated blood and used flow cytometry to determine the
percentage of each leukocyte subpopulation that bound parasites
after 5 min. Leukocyte subpopulations were identified with
fluorochrome-labeled anti-CD15 (for granulocytes), -CD14
(monocytes), -CD3 (T cells), -CD19 (B cells), -CD56
+ (NK cells)
and -CD209 (monocyte/dendritic cells) mAb. Data from a
representative experiment are shown (Fig. 5) in which fluorescence
intensity of each gated leukocyte subpopulation is represented in a
secondary plot against that of cell-bound CMFDA-labeled
promastigotes (FL-1) as the percentage of each subpopulation that
bound L. amazonensis (Fig. 5A) or L. donovani (Fig. 5B) parasites.
Cells of each subpopulation that bound promastigotes are
expressed as a percentage of total leukocytes in the sample
(Fig. 5C; mean for eight experiments). After 5 min incubation,
13% of leukocytes bound promastigotes, of which 10.7%60.15%
were CD14
+, 76.3%60.8% CD15
+, 2.7%60.1% CD3
+,
8.5%60.2% CD19
+, 1.3%60.02% CD3
2 CD56
+ and
0.49%60.03% CD209
+ cells. A substantial fraction of B cells
(8.5%) bound promastigotes in this early period. Granulocytes are
the main subpopulation that bound promastigotes; nevertheless,
the percentage of promastigote-binding cells in each subpopula-
tion was nearly identical for CD15
+ (19.162.4%), CD14
+
(17.3%62.3%) and CD19
+ (17.4%62.5%) (Fig. S6). Other
leukocyte subpopulations did not bind promastigotes appreciably.
Figure 3. Kinetics of the Leishmania immune adherence (IA) reaction in human blood. Aliquots (50 ml) of [
111In]-labeled promastigotes
(10
7cells/ml) were mixed with 50 ml heparinized blood and incubated (37uC) for the times indicated. Samples were then fractionated by
centrifugation (5006g/3 min) through 72% Percoll; free and erythrocyte-bound parasites were collected separately and [
111In] cpm determined in
each fraction. The IA kinetic profile is calculated as [
111In]-promastigote cpm bound to erythrocytes relative to total [
111In]-promastigote cpm at each
time point, and expressed as a percentage of maximum binding of triplicate samples from one representative experiment. (A) L. donovani (n=6), (B)
L. amazonensis (n=6). Insets: plots of L (IAmax/IAmax2IAti) against incubation time (ti), from which k
app values for Leishmania IA reaction were
obtained. Blood from three different donors was used and two experiments were performed for each blood sample.
doi:10.1371/journal.pntd.0000743.g003
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and internalization of promastigotes in human blood
We infected heparin-treated blood with CMFDA-labeled L.
amazonensis or L. donovani promastigotes. At various times post-
infection, granulocytes and monocytes were gated by SSC vs.
FSC, and the percentage of each subpopulation that bound
parasites was calculated in a secondary dot plot by representing
SSC-gated cells against fluorescence intensity of granulocyte- and
monocyte-bound CMFDA-labeled promastigotes (FL1). We si-
multaneously determined the percentage of granulocytes and
monocytes that internalized promastigotes by quenching fluores-
cence emitted by cell-bound complement-killed CMFDA-labeled
promastigotes, using trypan blue [45].
The time course of granulocyte and monocyte binding of
promastigotes was linear in the first 5 to 10 min of infection.
Promastigote concentration subsequently became limiting and the
kinetics followed a hyperbolic course; the binding reaction was
complete by 60 min (Fig. 6). After 30 min incubation, 39.2% of
granulocytes (,94% of total binding) had already bound L.
amazonensis and 45.1% (,90% of total binding) had bound L.
donovani promastigotes. At this time, 23.5% of monocytes (,76%
of total binding) had bound L. amazonensis and 20.2% (,75% of
total binding), L. donovani promastigotes. We analyzed leukocyte
binding and promastigote internalization in the period between 0
and 5 min, when the velocity of promastigote binding is
proportional with time and the cytolytic activity of complement
on Leishmania is probably not yet complete (Fig. 6A,B; insets). After
3 min incubation, the ratio of cells that bound:internalized
promastigotes was 12.9:5.4% for granulocytes and 8.9:2% for
monocytes (mean value of L. amazonensis and L. donovani); after
5 min, these values were 17.4:8.4% for granulocytes and
10.7:2.6% for monocytes.
Figure 4. Kinetics of promastigote propidium iodide (PI) uptake in NHS. For each time point, single aliquots (50 ml) of promastigotes
(10
7cells/ml) were mixed with 50 ml 50% pooled NHS and incubated (37uC) for the times indicated. Samples were then transferred into 1 ml PBS
containing PI (5 mg/ml), and promastigote membrane damage registered as PI uptake in a flow cytometer. The time course of promastigote PI uptake
is shown for a representative experiment. (A) L. donovani (n=5), and (B) L. amazonensis (n=4). Insets: plots of L (PImax/PImax2PIti) against incubation
time (ti), from which k
app values were derived for promastigote PI uptake reactions.
doi:10.1371/journal.pntd.0000743.g004
Table 1. On-rate constants of opsonization and immune adherence reactions of L. donovani and L. amazonensis promastigotes in
human blood.
L. donovani L. amazonensis
Reaction k
app (s
21)k +1 (M
21s
21)k
app (s
21)k +1 (M
21s
21) ,k+1
a)
Pm+IgM5RPm2IgM5 0.180 1.8610
660.050610
6 0.230 4.4610
660.050610
6 3.0610
6
Pm2IgM5+C3RPm2C3 0.061 3.5610
460.005610
4 0.063 3.6610
460.010610
4 3.5610
4
Pm-C3+ERPm-E 0.210 1.0610
860.040610
8 0.150 0.8610
860.020610
8 9.0610
7
Pm-C3+C5b-C9RPm Lysis 0.083 0.9610
660.005610
6 0.130 1.4610
660.008610
6 1.2610
6
aMean k+1 constant for L. amazonensis and L. donovani promastigotes.
doi:10.1371/journal.pntd.0000743.t001
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Phlebotomine sand flies transmit promastigotes to mammalian
hosts in two ways, by direct inoculation of parasites into a blood
pool in the skin or by their delivery into the interstitial space of the
dermis [4,14]. Here we used human blood as a surrogate model of
skin hematoma for a comprehensive kinetic analysis of promas-
tigote interactions with host blood components in the first minutes
of infection. As the time course of L. amazonensis and L. donovani
promastigote reactions were similar, we compiled only the data for
L. amazonensis (Fig. 7).
Figure 5. Blood leukocyte subpopulations that bind promastigotes in early infection. CMFDA-labeled promastigotes were incubated
(5 min) with heparinized blood and the percentage of each Leishmania-binding leukocyte subpopulation was measured by flow cytometry.
Leukocyte subpopulations were stained with fluorochrome-labeled mAb and identified in a dot plot as side scatter (SSC) vs. the specific fluorescent
label. The percentage of each promastigote-binding subpopulation was analyzed in a secondary plot representing the fluorescence intensity of each
gated mAb-labeled population vs. that of cell-bound CMFDA-labeled promastigotes. Dot plots of a representative experiment show cells in the gated
populations that bound CMFDA-labeled (A) L. amazonensis or (B) L. donovani promastigotes. (C) Cells of each subpopulation that bound
promastigotes expressed as a percentage of total leukocytes in the sample. Results are shown as the percentage (mean 6 SEM) of 14 experiments
performed with blood of six donors. (&) L. amazonesis,( ) L. donovani promastigotes.
doi:10.1371/journal.pntd.0000743.g005
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www.plosntds.org 10 July 2010 | Volume 4 | Issue 7 | e743Immediately after promastigote interaction with human blood,
natural anti-trypanosomatidIgM/IgGantibodiesboundtheparasite
with a hyperbolic course characteristic of first-order or pseudo-first
order reactions; in contrast, the kinetics of promastigote-C3
deposition, promastigote IA, and promastigote PI uptake showed
S-shaped curves, indicating cooperative (IA) or multimolecular (C3
deposition, PI uptake) mechanisms. Once opsonization was
triggered, all reactions proceeded simultaneously, and by ,2m i n
most parasites had been killed by complement activity. In human
blood, Leishmania survival probably depends on the relative rate by
which newly C3-opsonized promastigotes are incorporated into IA
and PI uptake reactions. The 75-fold greater velocity constant of the
promastigote IA (k+1, Pm IA,9610
7 M
21 sec
21) than that of
promastigote PI uptake (k+1, Pm PI,1.2610
6 M
21 sec
21)p e r m i t t e d
the IA reaction to be 50% complete by ,30 sec before parasite PI
uptake began. PI incorporation into promastigotes started ,50 sec
after serum contact, and required an additional 20 sec to reach 90%
maximum; due to these differences in reaction times, complement
killing begins at ,70 sec after serum contact. In this interval,
Leishmania IA can ferry promastigotes to blood leukocytes.
Leukocyte populations that express receptors for opsonic
ligands, principally C3 complement fragments, bound promasti-
Figure 6. Kinetics of leukocyte binding and internalization of L. amazonensis and L. donovani promastigotes in human blood. Aliquots
of heparinized human blood were infected with CMFDA-labeled L. amazonensis or L. donovani promastigotes and incubated (37uC) for various times
(0–60 min). Samples were then processed as indicated in Methods. To calculate the percentage of granulocytes and monocytes that bound and
internalized parasites, cells were gated by SSC vs. FSC and plotted independently in a secondary plot of SSC vs. FL1 (green, 530 nm). The percentage
of cells that internalized promastigotes was determined using trypan blue to quench the extracellular fluorescence emitted by cell-bound
complement-killed CMFDA-labeled promastigotes. (A) For L. amazonensis promastigotes: (a) Time course of granulocyte binding and internalization
(N) or internalization (#); (b) data from inset (shaded area) in (a); (c) time course of monocyte binding and internalization (N) or internalization (#);
(d) data from inset (shaded area) in (c). (B) Data as above (a–d) are shown for L. donovani. Results from seven (L. donovani) and ten (L. amazonensis)
experiments with blood from six donors.
doi:10.1371/journal.pntd.0000743.g006
Figure 7. Kinetics of L. amazonensis promastigote interactions with host components during early infection in blood. Kinetic data are
taken from the promastigote opsonization reactions shown in Figs. 1 to 4, and from the granulocyte and monocyte binding and internalization
reactions in Fig. 6. Promastigote-IgM binding (m), promastigote IA reaction (¤), promastigote-C3 binding (.), promastigote PI uptake (X),
granulocytes that bind and internalize promastigotes (N), granulocytes that internalize promastigotes (#), monocytes that bind and internalize
promastigotes (&) and monocytes that internalize promastigotes (%).
doi:10.1371/journal.pntd.0000743.g007
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the blood pool. In human blood, granulocyte concentration
exceeds that of monocytes, B cells and NK cells by 6- to 8-fold,
and that of natural killer (NK) and CD209
+ dendritic cells (DC-
SIGN) by two to three orders of magnitude; the latter constitute a
very small cell population (0.01–0.05%) that binds diverse
microorganisms in vitro, including promastigotes and axenic
amastigotes of Leishmania [46–48].
At 5 min post-infection, 13% of blood leukocytes bound
promastigotes in the proportion granulocytes (76.3%).monocytes
(10.7%).B lymphocytes (8.5).CD3
+ cells (2.7%).CD3
2CD56
+
cells (1.2%) cells.CD-209
+ cells (0.5%) (%Fig. 5C). This shows
that CD3
+, NK and DC-SIGN
+ cells have no relevant role in early
blood infection. In addition to granulocytes and monocytes,
,8.5% of B lymphocytes bound promastigotes; to our knowledge,
this interaction has not been previously reported. B cell binding of
opsonized promastigotes was confirmed with Raji lymphoblastoid
B cells, which bound C3-opsonized promastigotes to the same
extent as U937 monocytes (unpublished data). Promastigote-C3
binding by B cells is probably mediated by the IA reaction. In
autologous serum and in PBS/RPMI 1640 medium, human
erythrocytes transfer CR1-bound C3-opsonized promastigotes or
antigen-antibody immune complexes (IC) to granulocytes, mono-
cytes, B lymphocytes, and U937 cells [27,49–51]. Binding of C3-
opsonized promastigotes allows B lymphocytes to present antigens
to monocytes and macrophages through a CR2-mediated reaction
similar to the transfer of E-bound C3-IC to B cells [52]. B
lymphocytes have a still-undefined role in host immune response
to Leishmania. Early data showed that BALB/c mice depleted of B
cells by anti-IgM treatment had enhanced resistance to L. major
infection [53] and subsequent studies indicated that B lymphocytes
are involved in mouse susceptibility to Leishmania infection and
disease pathogenesis [54–57]. Our results confirm that B
lymphocytes have an early role in Leishmania immunity.
In the ex vivo Leishmania blood infection experiments,
promastigote inoculum was 5610
3 parasites/0.5 ml blood, a
1.8:1 promastigote:leukocyte ratio. Assuming that the number of
live opsonized promastigotes in the inoculum is 5%, 0.5 ml of host
blood would contain ,250 live parasites. In the first minutes after
infection, granulocytes and monocytes bound parasites at a
constant rate, and promastigote binding and ingestion was
detectable from 3 min incubation (Fig. 6, insets). At 5 min post-
infection, 17.4% of granulocytes bound promastigotes and 8.4%
carried TB-unquenched parasites; for monocytes these figures
were 10.7% and 2.6%, respectively. At that time, 8.5% of B cells
bound promastigotes, but did not internalize them (unpublished
data). To illustrate the number of Leishmania-infected leukocytes,
after 5 min incubation a 0.5 ml blood pool with 5.6610
6
leukocytes/ml (66.9% granulocytes, 6.9% monocytes) would have
,330 granulocytes with bound promastigotes, ,160 of which
would have surface-bound (live) and internalized (live and dead)
parasites. In the case of monocytes, there would be ,20 cells with
surface-bound promastigotes and ,5 cells with surface-bound and
internalized parasites.
The early period of Leishmania infection was recently addressed
in the mouse using intravital two-photon microscopy. Ng et al.
highlight the role of DDC in invasion, and showed that between
55 and 70% of DDC had ingested parasites by 2 to 3 h post-
infection [13]. Host neutrophil depletion before infection did not
affect the number of DDC that internalized promastigotes,
suggesting that these cells act independently of neutrophils. This
apparent lack of neutrophil involvement in infection control could
be due to the method of parasite inoculation or to the high
intradermal promastigote:DDC ratio used in these experiments. In
any case, the intradermal cell compartment is very different from
the hematoma environment; this experiment probably mimics
promastigote transmission in a bloodless context, and it is not
appropriate to compare it with the blood pool. In another study,
Peters et al. transmitted infection by intradermal injection of large
numbers of promastigotes or with infected flies fed ad libitum on
restrained mice [17]. Both inoculation methods are likely to have
caused dermic hematomas and to have induced substantial
neutrophil infiltrate at the injection site. One day post-infection,
,90% of infected neutrophils harbored live promastigotes; after a
week, all leishmanias were inside macrophages and DDC. This
change in host cells could be explained by the neutrophil Trojan
horse model, which proposes that macrophages are infected when
they dispose of apoptotic leukocytes [58]. Peters et al. [17] and
others [59] nonetheless consider that when infected neutrophils
become apoptotic, they release live promastigotes or amastigotes
that are phagocytosed by macrophages and DDC (‘‘Trojan rabbit
strategy’’).
To compare early Leishmania infection reactions in mouse and
man, we must consider that the earliest host-protective mecha-
nisms, serum complement and professional blood phagocytes,
differ in their anti-promastigote activity and in cell proportion in
these species. In human blood, the granulocyte:monocyte ratio is
6–7:1, whereas in mouse it is from 2–3:1 [60]. This is important, as
these cells are the main parasite targets during infection and
thereafter, when they are recruited to the inoculation site.
Persistence of neutrophils harboring promastigotes is considered
of paramount importance for subsequent disease development
[24,61–63].
We anticipate that the size of such a neutrophil reservoir would
differ between mouse and man. Human complement is highly
cytotoxic to promastigotes, whereas mouse complement is not
[28,64]. After inoculation, we estimate the number of live
promastigotes in human blood to be one twentieth of that in
mouse, which would considerably reduce the parasite load of
infected neutrophils.
Based on these data, we outline a kinetic model of Leishmania
infection in human blood that incorporates rate constants for
promastigote interactions, which measure the speed of these
reactions (Fig. 8). At 50 sec post-Leishmania inoculation, pro-
mastigote opsonization reactions are terminated and comple-
ment-dependent parasite killing has not begun, indicating that
rapid leukocyte uptake of promastigotes promotes Leishmania
survival in the host [23,27]. We suggest that a crucial step in
the infection pathway is determined by the high on-rate
constant of the Leishmania IA reaction. This mechanism
competes with complement-mediated parasite lysis by promot-
ing promastigote binding and internalization by granulocytes
and monocytes, and binding by B cells (Fig. 8). The substantial
number of promastigote-infected leukocytes in the blood pool is
probably sufficient to establish host infection. Nevertheless,
subsequent macrophage and DDC phagocytosis of promasti-
gotes released from neutrophils, or of apoptotic neutrophils,
would boost the parasite load during the early silent phase
post-infection.
During natural transmission, sand flies deliver salivary bioactive
components to the host, two of which could potentially interfere
with early infection mechanisms: saliva and fPPG (PSG). Sand fly
saliva inhibits hemostasis and facilitates feeding [65]. Mice
inoculated with sand fly salivary gland extracts show exacerbated
lesion development, which is associated with early (6 h) increase in
type-2 cytokine production and with early (2 to 4 h) expression of
macrophage-recruiting chemokines that promote inflammatory
cell influx to the injection site [66–68].
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exacerbation in mice [6]. fPSG facilitates early parasite establish-
ment by two mechanisms, macrophage recruitment to the
infection site and enhancement of alternative macrophage
activation, which upregulates arginase activity and promotes
amastigote growth [69]. Early leukocyte recruitment to the
infection site is detected in vivo from 40 min to 6 h [17] and in
vitro after 4 h; the effect of enhanced alternative macrophage
activation takes 24–48 h to develop [69]. In mouse, induction of
arginase mRNA peaks at day 3 post-stimulation [70] and in man,
leukocyte arginase is constitutively expressed only in granulocytes,
independently of proinflammatory or anti-inflammatory stimuli
[71]. In addition, neither PSG nor sand fly saliva appear to affect
macrophage phagocytosis of L. mexicana metacyclic promastigotes
[69]. We did not have access to PSG material and thus did not
examine PSG activity in our system. We therefore cannot assert
that PSG does not affect Leishmania early infection; nevertheless,
the data cited above strongly suggest that PSG and bioactive
salivary components exert their effects at a later stage of early
infection reactions. Future experiments will help clarify the PSG
effect on Leishmania ex vivo blood infection.
The most effective innate mechanism against pathogens is said to
be denial of access [72]. Leishmania has developed an extremely rapid
and effective infection strategy, and the prospect of blocking initial
promastigote access to a host seems highly improbable. Research
efforts should focus on development of therapeutic approaches to
prevent Leishmania establishment of permanent infection through
enhancement of macrophage leishmanicidal mechanisms.
Supporting Information
Figure S1 Leukocyte binding of promastigotes opsonized with
NHS or heat-inactivated serum. Aliquots (50 ml) aliquots of
heparinized blood were centrifuged (12006g, 10 min, 20uC) to
separate plasma from cells. Cells were washed twice by
centrifugation in PBS and adjusted to the initial blood volume
with NHS or heat-inactivated serum (56uC, 60 min; HIS).
Reconstituted blood aliquots were incubated (37uC, 5 min) with
CMFDA-labeled L. amazonensis promastigotes, and leukocyte-
promastigote interaction measured as in Fig. 2. Results are
expressed as percent (mean 6 SEM) of granulocytes (&) and
monocytes (%) that bound promastigotes. Data are derived from
three experiments, with blood of different donors.
Found at: doi:10.1371/journal.pntd.0000743.s001 (0.06 MB
TIF)
Figure S2 Time-course of PI uptake by L. amazonensis promas-
tigotes incubated with different concentrations of NHS. Single
aliquots (0.3 ml) containing L. amazonensis promastigotes (2610
5),
10 mg/ml PI, and serially diluted (50% to 0.78%) NHS were
incubated (37uC) for 1 to 9 min. PI uptake by parasites was
measured in real-time flow cytometry (FACSCalibur). Promasti-
gotes were identified and gated by SSC vs. FSC. PI emission was
measured in a dot plot of FL-2 (585/42 nm) vs. time (sec) and data
were analyzed with CELLQuest software (Becton Dickinson).
Time-course of percent promastigote PI uptake in different NHS
concentrations: 50% (N), 25% (#), 12.5% (.), 6.25% (n), 3.12%
(&), 1.56%(%) or 0.78% (¤).
Figure 8. Kinetic model of Leishmania infection in the human blood pool. Reaction pathway of promastigotes in host hematoma; k+1
constants show the frequency at which the reactions occur. Leishmania opsonization by natural antibodies and complement triggers promastigote IA
reaction and the complement cytolytic cascade that kills the parasite. The velocity of the IA reaction facilitates parasite transfer to granulocytes (1),
monocytes (2) and B lymphocytes (3), causing primary infection in granulocytes and monocytes. Infection can be boosted when parasitized
granulocytes that become apoptotic (4) release promastigotes, which are phagocytosed by newly recruited macrophages (5).
doi:10.1371/journal.pntd.0000743.g008
Time Course of Human Leishmania Infection
www.plosntds.org 13 July 2010 | Volume 4 | Issue 7 | e743Found at: doi:10.1371/journal.pntd.0000743.s002 (0.07 MB
TIF)
Figure S3 Percentage of apparently viable L. amazonensis
promastigotes determined by microscopy examination after
incubation in various concentrations of NHS. L. amazonensis
promastigotes (2610
7/ml) were incubated (37uC, 5 min) with
pooled NHS serially diluted (1/2) from 50% to 0.78%; the number
of apparently live parasites at each serum dilution was counted
under a light microscope.
Found at: doi:10.1371/journal.pntd.0000743.s003 (0.05 MB TIF)
Figure S4 Real-time kinetics of PI uptake by L. amazonensis
promastigotes in NHS, lepirudin- and heparin-treated plasma.
Blood samples drawn from healthy donors were immediately
centrifuged (12006g, 10 min, 20uC) to separate plasma from cells,
or left to coagulate at 20uC to obtain serum. CMFDA-labeled
promastigotes (5610
5) were incubated (37uC) in 200 ml aliquots
containing 10 mg/ml (final concentration) PI and 50% PBS-
diluted NHS or PBS-diluted plasma adjusted to 50 mg/ml final
concentration lepirudin (Refludin) or to 0, 10, 12.5, 15, 20, 40 or
80 IU/ml heparin. Parasite killing was measured as PI uptake in
real-time flow cytometry (FACSCalibur). Promastigotes were
identified and gated by SSC vs. FL-1. PI emission was measured
in a dot plot of FL-2 (585/42 nm) vs. time (208 sec). Data were
analyzed with CELLQuest software (Becton Dickinson). Time-
course of promastigote PI uptake in NHS (+), 50 mg/ml lepirudin-
treated plasma (&), plasma treated with heparin at 10 (#), 12.5
(%), 15 (e), 20 (^), 40 (n) or 80 (X) IU/ml. A representative
experiment is shown.
Found at: doi:10.1371/journal.pntd.0000743.s004 (0.05 MB TIF)
Figure S5 Granulocyte and monocyte binding of L. amazonensis
promastigotes in lepirudin (50 mg/ml) or heparin (10 IU/ml)-
treated blood. Aliquots of treated blood were infected with
CMFDA-labeled L. amazonensis promastigotes and incubated
(37uC) for various times (0–5 min). The reaction was terminated
by addition of 2 ml E lysing reagent. After 10 min incubation,
3 ml of sheath fluid was added and tubes were centrifuged (5006g,
5 min); the pellet was washed with 5 ml sheath fluid and
resuspended in 200 ml. To calculate the percentage of granulocytes
and monocytes that bound parasites, cells were gated by SSC vs.
FSC and plotted independently in a secondary plot of SSC vs.FL-1
(green, 530 nm). Results are expressed as the percentage (mean 6
SEM) of cells that bound parasites. Data are derived from three
experiments, each using blood from a different donor. Blood
treated with lepirudin (N) or heparin (#).
Found at: doi:10.1371/journal.pntd.0000743.s005 (0.08 MB TIF)
Figure S6 Illustrates the percentage of promastigote-binding
cells in each leukocyte subpopulation. The analysis was performed
as described in Methods for the determination of leukocyte
binding of promastigotes. Results are expressed as (mean 6 SEM)
of five experiments. (&)L. amazonensis,( %)L. donovani promasti-
gotes.
Found at: doi:10.1371/journal.pntd.0000743.s006 (0.11 MB TIF)
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